157 related articles for article (PubMed ID: 9038732)
41. Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients.
Omenai SA; Ajani MA; Okolo CA
PLoS One; 2022; 17(2):e0263615. PubMed ID: 35139126
[TBL] [Abstract][Full Text] [Related]
42. An immunohistochemical study of p53 protein in cervical intraepithelial neoplasia and squamous cell carcinoma.
Raju GC; Teh M; Wee A
Pathology; 1996 Jan; 28(1):17-19. PubMed ID: 8714263
[TBL] [Abstract][Full Text] [Related]
43. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer.
Wang JL; Zheng BY; Li XD; Angström T; Lindström MS; Wallin KL
Clin Cancer Res; 2004 Apr; 10(7):2407-14. PubMed ID: 15073118
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
45. [Expression of FHIT genes in CIN and cervical carcinoma and the relationship between FHIT gene and p53 and HPV16/18].
Zhang WM; Shuai CX; Zheng FY; Huang YP; Wang QJ; Zhu-Hua ; He QX
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):452-5. PubMed ID: 17152494
[TBL] [Abstract][Full Text] [Related]
46. Expression of matrix metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine cervix.
Nasr M; Ayyad SB; El-Lamie IK; Mikhail MY
Eur J Gynaecol Oncol; 2005; 26(2):199-202. PubMed ID: 15857029
[TBL] [Abstract][Full Text] [Related]
47. [Overexpression of p53 protein and its relation to HPV in squamous intraepithelial lesion and cervical carcinoma].
Li X; Mi R; Jiao S
Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):360-3. PubMed ID: 10374328
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas.
Baykal C; Ayhan A; Al A; Yüce K; Ayhan A
Gynecol Oncol; 2003 Feb; 88(2):123-9. PubMed ID: 12586590
[TBL] [Abstract][Full Text] [Related]
49. PRb2/p130, p107 and p53 expression in precancerous lesions and squamous cell carcinoma of the uterine cervix.
Cenci M; Pisani T; French D; Alderisio M; Vecchione A
Anticancer Res; 2005; 25(3B):2187-92. PubMed ID: 16158962
[TBL] [Abstract][Full Text] [Related]
50. Differences in the ARID-1 alpha expressions in squamous and adenosquamous carcinomas of uterine cervix.
Solakoglu Kahraman D; Diniz G; Sayhan S; Ayaz D; Uncel M; Karadeniz T; Akman T; Ozdemir A
APMIS; 2015 Oct; 123(10):847-50. PubMed ID: 26303865
[TBL] [Abstract][Full Text] [Related]
51. [Expression and clinical significance of Pin1 and Cyclin D1 in cervical cancer cell lines and cervical epithelial tissues].
Li HY; Xu Q; Zhu T; Zhou JH; Deng DR; Wang SX; Lu YP; Ma D
Ai Zheng; 2006 Mar; 25(3):367-72. PubMed ID: 16536997
[TBL] [Abstract][Full Text] [Related]
52. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
Loncaster JA; Cooper RA; Logue JP; Davidson SE; Hunter RD; West CM
Br J Cancer; 2000 Sep; 83(5):620-5. PubMed ID: 10944602
[TBL] [Abstract][Full Text] [Related]
53. Prognosis and treatment of primary adenocarcinoma and adenosquamous cell carcinoma of the uterine cervix.
Pekin T; Kavak Z; Yildizhan B; Kaya H
Eur J Gynaecol Oncol; 2001; 22(2):160-3. PubMed ID: 11446486
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of p53 expression in stage IB1 cervical carcinoma.
Chen HY; Hsu CT; Lin WC; Tsai HD; Chang WC
Gynecol Obstet Invest; 2000; 49(4):266-71. PubMed ID: 10828711
[TBL] [Abstract][Full Text] [Related]
55. [Expression of P53, COX2 and CD44V6 in early-stage squamous carcinoma of cervix with lymph vascular space invasion positive and negative and its relationship with prognosis].
Zhang R; Song Y; Gao WJ; Zhang X; Zuo J; Lei CZ; Wang Y
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3341-5. PubMed ID: 20193563
[TBL] [Abstract][Full Text] [Related]
56. Laminin-5 gamma 2 chain expression in cervical intraepithelial neoplasia and invasive cervical carcinoma.
Noel JC; Fernandez-Aguilar S; Fayt I; Buxant F; Ansion MH; Simon P; Anaf V
Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1119-23. PubMed ID: 16232183
[TBL] [Abstract][Full Text] [Related]
57. Analyzing simultaneous positive expression of EZH2 and P53 protein to improve predictive value in cervical squamous cell carcinoma.
Chen SQ; Zhang HM; Li JB; Jiang HY; Fan L; Kong LZ; Yao SZ
Int J Gynecol Cancer; 2014 Nov; 24(9):1653-8. PubMed ID: 25275664
[TBL] [Abstract][Full Text] [Related]
58. L1 cell adhesion molecule (L1CAM) in stage IB cervical cancer: distinct expression in squamous cell carcinomas and adenocarcinomas.
Mancusi de Carvalho JP; Salim RC; Carvalho FM; Nogueira Dias Genta ML; Baracat EC; Carvalho JP
J Clin Pathol; 2020 Nov; 73(11):748-753. PubMed ID: 32366597
[TBL] [Abstract][Full Text] [Related]
59. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours.
Saegusa M; Hashimura M; Machida D; Okayasu I
J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of co-overexpression of bcl-2 and c-erbB-2/neu in uterine cervix carcinomas and premalignant lesions.
Protrka Z; Arsenijević S; Arsenijević P; Mitrović S; Stanković V; Milosavljević M; Nedović J; Kastratović T; Durić J
Med Glas (Zenica); 2012 Aug; 9(2):248-55. PubMed ID: 22926359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
